Formulation and Characterization of RBCS Coated Carboplatin Loaded Nano‐Liposomal Formulation for Managing Breast Cancer
Drug Development Research · 2024-12 · 85 (8)
DOI: 10.1002/ddr.70019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 19.11.2024. Verfasst von Akhilesh Dubey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangaluru, Karnataka, India. Hauptthemen laut MEDLINE: Liposomes, Carboplatin, Antineoplastic Agents, Particle Size. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Cell membrane‐coated Nano‐Liposomes (CM‐NLPs) offer a promising approach that combines the advantages of both host cells and synthetic nano‐liposomes (NLPs). This technique involves coating liposomes with red blood cell (RBC) membranes to enhance their functionality. In this study, novel carboplatin‐loaded NLPs (CP‐NLPs) were formulated using phospholipids (Soya Phosphatidyl Choline) and cholesterol through the thin‐film hydration method, and optimized using a 3 2 full factorial design. The optimized CP‐NLPs were coated with RBC membranes, resulting in the formulation “CP‐RBCs‐NLPs.” These were characterized for particle size, zeta potential, entrapment efficiency, transmission electron microscopy (TEM), differential scanning calorimetry (DSC), protein content, in vitro drug release, cell viability, and stability. The optimized CP‐RBCs‐NLPs exhibited a particle size of 103.6 nm, with zeta potential values of −27.3 mV indicating good stability. The entrapment efficiency was approximately 56%, and the drug release profile showed sustained release for up to 8 h. Cytotoxicity studies in human triple‐negative breast cancer (MDA‐MB468) cell lines demonstrated that CP‐RBCs‐NLPs effectively delivered the drug into target cells, facilitating cell death due to their bilayer structure similar to cell membranes. Overall, CP‐RBCs‐NLPs outperformed both carboplatin‐loaded conventional NLPs (CP‐CNLPs) and carboplatin‐conventional solution (CP‐CNS), making it a superior formulation for drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangaluru, Karnataka, India.
- Formulation and Development, Viatris R&D Centre, Bengaluru, India.
- Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
- Department of Pharmaceutical Chemistry, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangaluru, Karnataka, India.
- Department of Pharmaceutics and Industrial Pharmacy, PharmD Program, Egypt-Japan University of Science and Technology (E-JUST), Alexandria, Egypt.
ORCID-Profile: Akhilesh Dubey, Sally A El-Zahaby
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Dubey, A., Raju, F., Lobo, C. L., Gs, R., Hebbar, S., Shetty, A., Kumar, P., & El-Zahaby, S. A. (2024). Formulation and Characterization of RBCS Coated Carboplatin Loaded Nano‐Liposomal Formulation for Managing Breast Cancer. Drug Development Research, 85(8). https://doi.org/10.1002/ddr.70019
Vancouver
Dubey A, Raju F, Lobo CL, Gs R, Hebbar S, Shetty A, et al. Formulation and Characterization of RBCS Coated Carboplatin Loaded Nano‐Liposomal Formulation for Managing Breast Cancer. Drug Development Research. 2024;85(8). doi:10.1002/ddr.70019
BibTeX
@article{Dubey2024,
author = {Dubey, Akhilesh and Raju, Faby and Lobo, Cynthia Lizzie and Gs, Ravi and Hebbar, Srinivas and Shetty, Amitha and Kumar, Pankaj and El-Zahaby, Sally A},
title = {Formulation and Characterization of RBCS Coated Carboplatin Loaded Nano‐Liposomal Formulation for Managing Breast Cancer},
journal = {Drug Development Research},
year = {2024},
volume = {85},
number = {8},
doi = {10.1002/ddr.70019}
}
EUVIMED